Staphylococcus aureus

June 4, 2019June 4, 2019

Phage Therapy May Help Resolve Multidrug-resistant Pseudomonas Airway Infections, Case Report Suggests

cystic fibrosis, News

Armata Pharmaceuticals‘ investigational phage therapy AP-PA01 combined with antibiotics holds promise for treating multidrug-resistant Pseudomonas airway infections, updated data from a case study show. A young woman with cystic ... Read more

May 16, 2019May 16, 2019

Poor Oxygen Conditions May Promote P. aeruginosa Infection Over Other Pathogen in CF, Study Suggests

cystic fibrosis, News

Poor oxygen conditions, a common trait in the lungs of cystic fibrosis (CF) patients, may help Pseudomonas aeruginosa bacteria outcompete other infectious agents, namely Staphylococcus aureus, a study suggests. The ... Read more

May 1, 2019May 1, 2019

Decreasing Acidity of Airway Liquid in Newborn CF Patients May Reduce Infection Risk, Study Suggests

cystic fibrosis, News

Normalizing the acidity in the thin layer of liquid covering the airways of newborns with cystic fibrosis might make them more resistant to bacterial infections, a study has found. The study’s researchers ... Read more

April 16, 2019April 16, 2019

Early Antibiotic Treatment Better to Eradicate New MRSA Infections in CF Patients, Study Suggests

cystic fibrosis, News

Using antibiotics to fully eliminate new methicillin-resistant Staphylococcus aureus (MRSA) airway infections appears more effective than waiting for the infection to pass naturally in patients with cystic fibrosis (CF), a ... Read more

March 26, 2019May 16, 2019

Asthma Medicine Xolair Successfully Treats Lung Allergy Due to Fungal Infection in 3 CF Patients, Case Report Shows

cystic fibrosis, News

Xolair (omalizumab), a medicine used for allergic asthma and chronic hives, is effective for treating lung allergic reactions caused by fungi in patients with cystic fibrosis (CF), a case ... Read more

March 22, 2019March 22, 2019

New Strategy May Boost Antibiotics’ Efficacy in CF Patients, Study Suggests

cystic fibrosis, News

Removing a key metabolite called pyruvate from Pseudomonas aeruginosa and Staphylococcus aureus bacteria biofilms — two of the most common bacteria found in cystic fibrosis (CF) patients — could ... Read more

October 10, 2018October 10, 2018

Bicarbonate Eyed as Weapon to Combat 2 Most Prevalent Bacteria in CF

cystic fibrosis, News

Adding bicarbonate, a salt, to the culture medium of Pseudomonas aeruginosa and Staphylococcus aureus, two of the most common bacteria underlying lung infections in people with cystic fibrosis (CF), impairs ... Read more

August 30, 2018August 30, 2018

MRSA Difficult to Eradicate, Even With Multimodal Antibiotics, CF Study Finds

cystic fibrosis, News

Up to one month of treatment with inhaled vancomycin, the antibiotic of choice for treating most methicillin-resistant Staphylococcus aureus (MRSA) infections, together with a combination of oral and topical antibiotics, failed to ... Read more

June 26, 2018June 26, 2018

Neem Biotech Earns Award from UK Cystic Fibrosis Trust to Expand CF Program

cystic fibrosis, News

Wales-based Neem Biotech recently received a Venture & Innovation Award from the U.K. Cystic Fibrosis Trust to develop new antimicrobial intervention strategies as part of its cystic fibrosis (CF) ... Read more

March 26, 2018June 3, 2019

Many CF Patients Have Long-term Staphylococcus Aureus Infections, Study Shows

cystic fibrosis, News

Many cystic fibrosis patients have long-term Staphylococcus aureus infections, with the bacteria’s resistance to antibiotics fluctuating over time, a study reports. Chronic and recurrent infection of the airways is the most ... Read more

Pin It on Pinterest